Nucleus RadioPharma is a startup that operates as a Contract Development and Manufacturing Organization (CDMO). In simpler terms, it provides services to help other companies develop and manufacture their products, specifically in the field of targeted radiotherapies. These are treatments that use radioactive substances to specifically target and kill cancer cells.

The company's clients are innovators in the healthcare sector who are developing promising drug candidates. Nucleus RadioPharma helps them turn these candidates into commercially successful medicines by providing services like product development, regulatory expertise, manufacturing infrastructure, and supply chain networks.

The company's business model is based on providing end-to-end support to its clients. This means that it helps clients at every stage of their product lifecycle, from formulation and analytical development to regulatory documentation, drug product manufacturing, and distribution to patients.

Nucleus RadioPharma is also strategically located near prominent medical centers and key distribution hubs. This allows the company to access large clinical trial networks and deliver products to patients quickly.

The company's services are flexible and designed to expand as demand increases. This means that clients can come to Nucleus RadioPharma at any point in their product lifecycle and receive the services they need to advance their program.

In terms of revenue, Nucleus RadioPharma makes money by charging its clients for the services it provides.

Keywords: Contract Development and Manufacturing Organization, targeted radiotherapies, product development, regulatory expertise, manufacturing infrastructure, supply chain networks, end-to-end support, strategic location, flexible services, revenue generation.